Joshua M Wieder Md Inc - 90024 Los Angeles, CA

Business Name: Joshua M Wieder Md Inc
Categorized In: Doctors
Address: 100 Ucla Medical Plaza # 730, Los Angeles, CA 90024
Phone Number: (808) 961-3622
Contact Person: Joshua Wieder
Website Address: wiederderm.com
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 1996
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Ghadishah Delaram MD - Los Angeles, CA 90024
Goodman Linda S PhD - Los Angeles, CA 90024
Kabbinavar Fairooz F MD - Los Angeles, CA 90024
Daley Melita L MD - Los Angeles, CA 90024
Rittman Thomas MD - Los Angeles, CA 90024
Dorin Ashley G MD - Los Angeles, CA 90024
Capone-Newton Peter MD - Los Angeles, CA 90024
Boyadzhyan Lousine L MD - Los Angeles, CA 90024
Forgey Marcy J MD - Los Angeles, CA 90024
Fleisher Carl MD - Los Angeles, CA 90024
Friedman Jodi MD - Los Angeles, CA 90024
Green Jonas MD - Los Angeles, CA 90024
Azari Kodi MD - Los Angeles, CA 90024
Paranay Gregory L MD - Los Angeles, CA 90024
Hansen Brooke M MD - Los Angeles, CA 90024
Caudill Marissa M MD - Los Angeles, CA 90024
Maguen Ezra MD - Los Angeles, CA 90024
Shah Bhavik G MD - Los Angeles, CA 90024
Morris Brian MD - Los Angeles, CA 90024
Bengs Benjamin MD - Los Angeles, CA 90024

Joshua M Wieder Md Inc provides professional Doctors from its single location at the coordinates 34.066825,-118.445308.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 1996, the company can now be visited at 100 Ucla Medical Plaza # 730, Los Angeles, California 90024 or contacted through representative Joshua Wieder at (808) 961-3622.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Joshua M Wieder Md Inc through its company website at wiederderm.com. Engage with this business on its social media platforms through on Twitter and on Facebook.